Thermo Fisher Scientific Inc. (TMO) |
527.91 -6.77 (-1.27%) 10-10 14:23 |
Open: | 534.83 |
High: | 537.93 |
Low: | 525.7365 |
Volume: | 764,751 |
Market Cap: | 199,345(M) |
PE Ratio: | 30.57 |
Exchange: | New York Stock Exchange |
Industry: | Medical - Diagnostics & Research |
Sector: | Healthcare |
Technical analysis | ||||
![]() |
||||
sell | buy |
Resistance 2: | 641.75 |
Resistance 1: | 549.44 |
Pivot price: | 504.23 |
Support 1: | 492.11 |
Support 2: | 456.67 |
52w High: | 610.97 |
52w Low: | 385.46 |
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
EPS | 17.270 |
Book Value | 133.770 |
PEG Ratio | 0.00 |
Gross Profit | 47.245 |
Profit Margin (%) | 15.24 |
Operating Margin (%) | 17.84 |
Return on Assets (ttm) | 5.0 |
Return on Equity (ttm) | 13.4 |
Fri, 10 Oct 2025
Thermo Fisher Scientific (NYSE:TMO) Price Target Raised to $650.00 - MarketBeat
Fri, 10 Oct 2025
What to Expect From Thermo Fisher’s Q3 2025 Earnings Report - Yahoo Finance
Fri, 10 Oct 2025
Baxter Bros Inc. Has $8.55 Million Stake in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Fri, 10 Oct 2025
Boomfish Wealth Group LLC Boosts Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Fri, 10 Oct 2025
Copperwynd Financial LLC Buys 601 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Fri, 10 Oct 2025
Blair William & Co. IL Cuts Stake in Thermo Fisher Scientific Inc. $TMO - MarketBeat
![]() StockChart iOS |
![]() StoxlineLite iOS |
![]() StoxlineLite iOS |
![]() OptionCalc iOS |
![]() StockChart Android |
![]() StoxlineLite Android |
![]() StoxlinePro Android |
![]() OptionCalc Android |